Communicated by Michel Goossens
Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants†
Article first published online: 11 MAY 2012
© 2012 Wiley Periodicals, Inc.
Volume 33, Issue 8, pages 1228–1238, August 2012
How to Cite
Houdayer, C., Caux-Moncoutier, V., Krieger, S., Barrois, M., Bonnet, F., Bourdon, V., Bronner, M., Buisson, M., Coulet, F., Gaildrat, P., Lefol, C., Léone, M., Mazoyer, S., Muller, D., Remenieras, A., Révillion, F., Rouleau, E., Sokolowska, J., Vert, J.-P., Lidereau, R., Soubrier, F., Sobol, H., Sevenet, N., Bressac-de Paillerets, B., Hardouin, A., Tosi, M., Sinilnikova, O. M. and Stoppa-Lyonnet, D. (2012), Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants. Hum. Mutat., 33: 1228–1238. doi: 10.1002/humu.22101
- Issue published online: 13 JUL 2012
- Article first published online: 11 MAY 2012
- Accepted manuscript online: 13 APR 2012 03:52PM EST
- Manuscript Accepted: 30 MAR 2012
- Manuscript Revised: 15 MAR 2012
- Manuscript Received: 9 DEC 2011
- Institut National du Cancer
Additional Supporting information may be found in the online version of this article
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.